Aparna Raj Parikh: Standing platform to accelerate ctDNA based clinical trials
Aparna Raj Parikh shared a post on X about a recent paper by Arielle Medford et al. published in Nature Reviews Cancer.
“A standing platform for cancer drug development using ctDNA-based evidence of recurrence”
Authors: Arielle Medford, Ariel Carmeli, Alexandra Ritchie, Nikhil Wagle, Levi Garraway, Eric Lander and Aparna Parikh.
“Idea now happening. standing platform to accelerate ctDNA based clinical trials. Proud to be leading this! Mass General Cancer Center, Science for America along with Arielle Medford, Scott Kopetz, Van Morris, Arvind Dasari, Neil Segal, Meredith Pelster, Nikhil Wagle and others!
Pilot phase in CRC but plan to expand to other tumor types and have both a few academic sites and community sites for phase 1. Excited to see if we can facilitate learning and drug development in this space!”
Source: Aparna Raj Parikh/X
More posts featuring Aparna Raj Parikh on oncodaily.com
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023